fine
Teva agrees $225 million fee in antitrust case
January 27, 2017Medical Communications Barr Laboratories, Teva, fine
Barr Laboratories, a subsidiary of Teva Pharmaceuticals, has settled an antitrust class action for $225 million. The case relates to …
Teva hit with record fine $519 million corruption fine
December 23, 2016Medical Communications Teva, corruption, fine
Teva Pharmaceuticals, the world’s largest generics company, has been hit with the largest criminal fine to come from the US …
Pfizer slapped with record £84.2 million fine for 2,600% price increase
December 7, 2016Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine
Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
Pfizer fined for epilepsy drug price increase by UK antitrust regulator
April 15, 2016Medical Communications CMA, Flynn Pharma, Pfizer, antitrust, competition and markets authority, epilepsy, fine, flynn
Pfizer has been fined for unfairly increasing the price of epilepsy drug Epanutin (phenytoin sodium) by the UK Competition and …
J&J hit with $2.2 billion fine
November 5, 2013Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine
Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …
Ranbaxy unit fined $500m for selling adulterated drugs
May 14, 2013Manufacturing and Production FDA, GMP, Ranbaxy, fine, generics
Ranbaxy’s US subsidiary has agreed to pay fines and penalties totalling $500 million after pleading guilty to charges of manufacturing …
Latest content
FibroFind appoints Lee Borthwick as CEO
